West Pharmaceutical Services, Inc. (WST)
WST Stock Jumps on Q1 Earnings & Sales Beat, EPS View Up on HVP Growth
West Pharmaceutical posts 46.9% EPS growth and beats estimates as strong segment demand lifts revenues, prompting a higher 2026 outlook and margin expansion.
West Pharmaceutical Services, Inc. (WST) Q1 2026 Earnings Call Transcript
West Pharmaceutical Services, Inc. (WST) Q1 2026 Earnings Call Transcript
Compared to Estimates, West Pharmaceutical (WST) Q1 Earnings: A Look at Key Metrics
The headline numbers for West Pharmaceutical (WST) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates
West Pharmaceutical Services (WST) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.45 per share a year ago.
West Pharma lifts 2026 profit forecast on strong demand for medical equipment
West Pharmaceutical on Thursday raised its annual profit and revenue forecasts after beating estimates for first-quarter results, betting on strong demand for its proprietary products that include syringes and cartridges for injectable drugs.
WST Likely to Beat Q1 Earnings Estimates: How to Play the Stock?
WST enters Q1 earnings with strong momentum, steady GLP-1 demand, and growth across high-value products, positioning it for another potential beat.
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now
WST rides strong HVP demand and GLP-1 expansion, but tariffs, destocking pressures and European facility constraints pose near-term growth risks.
West Pharmaceutical Services (WST) Reports Next Week: Wall Street Expects Earnings Growth
West Pharmaceutical (WST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
WST Expands Dublin Facility to Boost Injectable Therapy Capacity
West Pharmaceutical expands Dublin facility to boost injectable therapy capacity and strengthen its end-to-end manufacturing platform.
West Pharmaceutical Services, Inc. (WST) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
West Pharmaceutical Services, Inc. (WST) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
Cinctive Capital Management LP Makes New $3.76 Million Investment in West Pharmaceutical Services, Inc. $WST
Cinctive Capital Management LP bought a new stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 14,319 shares of the medical instruments supplier's stock, valued at approximately $3,756,000. Other institutional
Brown Brothers Harriman & Co. Has $64.89 Million Holdings in West Pharmaceutical Services, Inc. $WST
Brown Brothers Harriman and Co. lifted its holdings in West Pharmaceutical Services, Inc. (NYSE: WST) by 22.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 247,356 shares of the medical instruments supplier's stock after purchasing an
